Pipeline

The Centre of Excellence in Cellular Immunotherapy Development Program accelerates the development of promising cellular therapies, leveraging comprehensive capabilities and expertise to swiftly advance into first-in-human clinical trials.

Learn more

Innovation Pipeline

Pipeline Projects
Haem Program
platform CD19 CAR
platform BCMA CAR
MM KMA CAR
Solid Tumours
Armored HER2 CAR
PRE-CLINICAL
MANUFACTURING R&D
TECH TRANSFER*
PHASE 1 CLINICAL TRIAL
Collaborative Projects
BCMA (CAR-T Imaging)**
NextGen DC1***
PRE-CLINICAL
MANUFACTURING R&D
TECH TRANSFER*
PHASE 1 CLINICAL TRIAL
Haematology
Solid Tumour

*Done by our manufacturing partners Cell Therapies
**PMCC sponsored collaborative study with pharma
*** MRFF Funded in collaboration with WEHI

Updated March 2026

Expression of Interest

Please tell us about your project and we will come back to you.
If you have any questions, please contact us.